Cellmid Limited announced that Phillip Christopher has been appointed to the Board of Cellmid as a non-executive director, effective on 5 November 2021. Phillip will stand for election at the upcoming general meeting of the shareholders and may remain on the Board of Cellmid while HGL Limited has an interest equal or greater than 5% in Cellmid. Phillip is Investment Director of HGL Limited where he has been responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by Cellmid. Phillip also spent 6 years at Alceon Group where he was a director in the private equity team which made significant investments in e-commerce and proprietary brand-based businesses. Prior to that he was a member of the investment banking division of Goldman Sachs. Phillip is a director of Pegasus Healthcare and was previously an alternate director of Marlin Brands.